AVEO Pharmaceuticals, Inc. (AVEO) financial statements (2020 and earlier)

Company profile

Business Address ONE BROADWAY
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:582434233452119
Cash and cash equivalents58241515275251
Short-term investments  1988 68
Other undisclosed cash, cash equivalents, and short-term investments (0)0    
Restricted cash and investments     3 
Receivables1301521
Other undisclosed current assets10162219
Total current assets:602850264059129
Noncurrent Assets
Property, plant and equipment    01114
Restricted cash and investments      3
Other noncurrent assets  00000
Other undisclosed noncurrent assets   1   
Total noncurrent assets:  0101217
TOTAL ASSETS:602850274171146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities465461420
Accounts payable2322134
Accrued liabilities23224913
Employee-related liabilities     22
Deferred revenue2
Debt93 221210
Deferred revenue and credits011112
Contract with customer, liability2
Other liabilities001   1
Other undisclosed current liabilities5726443(2)
Total current liabilities:21183210124031
Noncurrent Liabilities
Long-term debt and lease obligation9161812799
Long-term debt, excluding current maturities9161812799
Liabilities, other than long-term debt11214073136
Deferred revenue and credits123036
Deferred revenue3
Contract with customer, liability4
Other liabilities111111 
Derivative instruments and hedges, liabilities817385   
Other undisclosed noncurrent liabilities0 0    
Total noncurrent liabilities:20375919111045
Total liabilities:41559129235076
Stockholders' equity
Stockholders' equity attributable to parent19(27)(41)(2)172170
Common stock0000000
Additional paid in capital600568546520512501497
Accumulated other comprehensive income (loss) 0(0)0(0) (0)
Accumulated deficit(581)(595)(587)(522)(495)(480)(427)
Total stockholders' equity:19(27)(41)(2)172170
TOTAL LIABILITIES AND EQUITY:602850274171146

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:3058319181
Operating expenses(30)(31)(36)(32)(31)(69)(105)
Operating loss:(0)(25)(29)(29)(12)(50)(104)
Nonoperating income (expense)3620(36)3(3)(2)(3)
Interest and debt expense(2)(2)(2)(2)(2)(2)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes1222   
Income (loss) from continuing operations before income taxes:34(5)(65)(27)(17)(55)(110)
Income tax expense  (0)(0)   
Income (loss) before gain (loss) on sale of properties:34(5)(65)(27)(17)(55)(110)
Other undisclosed net income1      
Net income (loss):35(5)(65)(27)(17)(55)(110)
Other undisclosed net income attributable to parent1   223
Net income (loss) available to common stockholders, basic:36(5)(65)(27)(15)(53)(107)
Dilutive securities, effect on basic earnings per share(9)(20)     
Other undisclosed net loss available to common stockholders, diluted(20)      
Net income (loss) available to common stockholders, diluted:7(25)(65)(27)(15)(53)(107)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):35(5)(65)(27)(17)(55)(110)
Comprehensive income (loss):35(5)(65)(27)(17)(55)(110)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10(0)0223
Comprehensive income (loss), net of tax, attributable to parent:36(5)(65)(27)(15)(53)(107)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: